NCT07656857 High-density Flexible μECoG for Epilepsy Surgery - A Single-Arm ECT
| NCT ID | NCT07656857 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tiantan Hospital |
| Condition | Focal Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 85 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 85 participants in total. It began in 2026-09-01 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
What's the clinical value of high-density flexible microelectrocorticography (μECoG) for guiding the resection of epileptogenic zone (EZ) in epilepsy surgery?
Eligibility Criteria
Inclusion Criteria: 1. Age 3 to 60 years. 2. Diagnosis of drug-resistant epilepsy, defined as persistent seizures despite treatment with two or more appropriately selected, adequately dosed and adequately tried antiseizure medications. 3. Diagnosis of focal epilepsy after standard presurgical evaluation and considered suitable for resective epilepsy surgery. 4. Preoperative cognitive or developmental status sufficient to participate in study assessments, as judged by the investigator and assessed using age-appropriate validated instruments. For participants aged 3 to 6 years, developmental status must be within the normal range according to the Griffiths Mental Development Scales. For participants aged 6 to 16 years, cognitive function must be within the normal range according to the Wechsler Intelligence Scale for Children. For participants older than 16 years, a Mini-Mental State Examination score of 24 or higher will be required. 5. Written informed consent provided by the participant or, when applicable, by a legal guardian. Exclusion Criteria: 1. Suspected mesial temporal lobe epilepsy after multidisciplinary presurgical evaluation. 2. History of any previous neurosurgical craniotomy before epilepsy surgery. 3. Severe psychiatric, cognitive, or psychological disorder that prevents participation in the study or completion of follow-up. 4. Contraindication to surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07656857 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 60 Years, studying Focal Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07656857 currently recruiting?
Yes, NCT07656857 is actively recruiting participants. Contact the research team at zhangkai62035@sina.com for enrollment information.
Where is the NCT07656857 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07656857 clinical trial?
NCT07656857 is sponsored by Beijing Tiantan Hospital. The trial plans to enroll 85 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.